The pandemic reminded the world of the importance of vaccines, and demonstrated the extraordinary ability of health professionals to innovate. And the latest developments in medical technology are another giant leap forward.

Needle-free vaccines might sound a little bit like science fiction - but clinical trials have shown it’s not just possible, but it can improve the effectiveness of a vaccine’s immune response. David Hoey, President and CEO of Vaxxas, talks to Sean about the company's needle-free technology, developed and commercialised in Brisbane.

This interview is supported by the Brisbane Economic Development Agency.